Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling
Ali Bashashati(University of British Columbia), Sohrab P. Shah(Memorial Sloan Kettering Cancer Center), Michael S. Anglesio(University of British Columbia), C. Blake Gilks(Vancouver General Hospital), Winnie Yang(BC Cancer Agency), Gavin Ha(AstraZeneca (United Kingdom)), Stephen Yip(University of British Columbia), Yongjun Zhao(Canada's Michael Smith Genome Sciences Centre), Jiarui Ding(Broad Institute), Melissa K. McConechy(Contextual Change (United States)), Alicia Tone(BC Cancer Agency), Leah Prentice(University of British Columbia), Andrew Roth(Canadian Centre for Applied Research in Cancer Control), Jessica N. McAlpine(University of British Columbia), Marco A. Marra(University of British Columbia), Jamie Rosner(University of British Columbia), Karey Shumansky(Canadian Centre for Applied Research in Cancer Control), Janine Senz(University of British Columbia), David G. Huntsman(BC Cancer Agency), Steve E. Kalloger(BC Cancer Agency), Richard A. Moore(Canada's Michael Smith Genome Sciences Centre), Thomas Zeng(Canada's Michael Smith Genome Sciences Centre), Nataliya Melnyk(BC Cancer Agency), Margaret Luk(Vancouver General Hospital), Kane Tse(Canada's Michael Smith Genome Sciences Centre)
Cited by 434
Related Papers
The NIH Roadmap Epigenomics Mapping Consortium
|Nature Biotechnology|2010|2k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
|New England Journal of Medicine|2010|1.3k